Otonomy, Inc. IPO Research Information

Otonomy, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Otonomy, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Otonomy, Inc.	OTIC - NASDAQ	$14.00-$16.00	$16.00	$18.13	6.25 million	8/13/2014
Underwriter(s): J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): Piper Jaffray, Sanford C. Bernstein
Industry: Health Care
Filing(s): Filed 2014-07-11 Terms Added 2014-08-01

Otonomy, Inc. Quote & Chart - Click for current quote - OTIC

About Otonomy, Inc. (adapted from Otonomy, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of diseases and disorders of the ear.

This description is adapted from Otonomy, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Otonomy, Inc. "OTIC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.